Findings hold promise for developing regenerative therapies for spinal cord injuries and diseases such as multiple sclerosis
Stem cell technology has long offered the hope of regenerating tissue to repair broken or damaged neural tissue. Findings from a team of UC Davis investigators have brought this dream a step closer by developing a method to generate functioning brain cells that produce myelin — a fatty, insulating sheath essential to normal neural conduction.
“Our findings represent an important conceptual advance in stem cell research,” said Wenbin Deng, principal investigator of the study and associate professor at the UC Davis Department of Biochemistry and Molecular Medicine. “We have bioengineered the first generation of myelin-producing cells with superior regenerative capacity.”
The brain is made up predominantly of two cell types: neurons and glial cells. Neurons are regarded as responsible for thought and sensation. Glial cells surround, support and communicate with neurons, helping neurons process and transmit information using electrical and chemical signals. One type of glial cell — the oligodendrocyte — produces a sheath called myelin that provides support and insulation to neurons. Myelin, which has been compared to insulation around electrical wires that helps to prevent short circuits, is essential for normal neural conduction and brain function; well-recognized conditions involving defective myelin development or myelin loss include multiple sclerosis and leukodystrophies.
In this study, the UC Davis team first developed a novel protocol to efficiently induce embryonic stem cells (ESCs) to differentiate into oligodendroglial progenitor cells (OPCs), early cells that normally develop into oligodendrocytes. Although this has been successfully done by other researchers, the UC Davis method results in a purer population of OPCs, according to Deng, with fewer other cell types arising from their technique.
They next compared electrophysiological properties of the derived OPCs to naturally occurring OPCs. They found that unlike natural OPCs, the ESC-derived OPCs lacked sodium ion channels in their cell membranes, making them unable to generate spikes when electrically stimulated. Using a technique called viral transduction, they then introduced DNA that codes for sodium channels into the ESC-derived OPCs. These OPCs then expressed ion channels in their cells and developed the ability to generate spikes.
According to Deng, this is the first time that scientists have successfully generated OPCs with so-called spiking properties. This achievement allowed them to compare the capabilities of spiking cells to non-spiking cells.
In cell culture, they found that only spiking OPCs received electrical input from neurons, and they showed superior capability to mature into oligodendrocytes.
They also transplanted spiking and non-spiking OPCs into the spinal cord and brains of mice that are genetically unable to produce myelin. Both types of OPCs had the capability to mature into oligo-dendrocytes and produce myelin, but those from spiking OPCs produced longer and thicker myelin sheaths around axons.
“We actually developed ‘super cells’ with an even greater capacity to spike than natural cells,” Deng said. “This appears to give them an edge for maturing into oligodendrocytes and producing better myelin.”
It is well known that adult human neural tissue has a poor capacity to regenerate naturally. Although early cells such as OPCs are present, they do not regenerate tissue very effectively when disease or injury strikes.
Deng believes that replacing glial cells with the enhanced spiking OPCs to treat neural injuries and diseases has the potential to be a better strategy than replacing neurons, which tend to be more problematic to work with. Providing the proper structure and environment for neurons to live may be the best approach to regenerate healthy neural tissue. He also notes that many diverse conditions that have not traditionally been considered to be myelin-related diseases – including schizophrenia, epilepsy and amyotrophic lateral sclerosis (ALS) – actually are now recognized to involve defective myelin.
The Latest Bing News on:
Stem cell technology
- MIT Technology Reviewon May 9, 2024 at 4:20 pm
A small brain sample was sliced into 5,000 pieces, and machine learning helped stitch it back together.
- Regina police install technology to detect breathing, heart rates of people in cellson May 9, 2024 at 11:33 am
The Regina Police Service (RPS) has outfitted some of its cells with health monitoring technology that alerts staff if someone goes into medical distress.A device mounted on the ceiling of a cell uses ...
- Harnessing Sunlight Like Never Before: Hemispherical Solar Cells Unleash Unmatched Absorptionon May 9, 2024 at 4:17 am
New research suggests redesigning organic solar cells with a hemispherical shell structure to provide broader angular coverage, which is particularly beneficial for devices that need adaptable light ...
- As Ozzy Osbourne announces stem cell therapy, experts urge caution, highlight riskson May 9, 2024 at 2:00 am
As rock legend Ozzy Osbourne has turned to stem cell therapy, some experts caution that the treatment is not for everyone. A doctor weighed in on the potential risks.
- Powering drones with ultra-thin, flexible perovskite PV cellson May 9, 2024 at 1:07 am
An Austrian research team has demonstrated lightweight, flexible and ultra-thin perovskite solar technology in palm-sized autonomous drones, showcasing the stability and energy-harvesting potential of ...
- New technique bioprints live cells inside the body using ultrasonic waveson May 8, 2024 at 10:36 pm
Revolutionary acousto-printing method can be used to circumvent invasive surgery, and has a wide array of potential applications.
- Scientists make advancements with groundbreaking binary organic solar cell technology: 'Highly efficient and stable'on May 8, 2024 at 5:30 pm
The scientists are improving the technology while also making the cells easier to place. Scientists make advancements with groundbreaking binary organic solar cell technology: 'Highly efficient and ...
- New technology changes how proteins in individual cells are studiedon May 8, 2024 at 7:13 am
Researchers from Karolinska Institutet, together with Pixelgen Technologies, have developed and applied a technique that makes it possible to map proteins in individual cells in a completely new way.
- 'Better than graphene' material development may improve implantable technologyon May 7, 2024 at 4:24 pm
Move over, graphene. There's a new, improved two-dimensional material in the lab. Borophene, the atomically thin version of boron first synthesized in 2015, is more conductive, thinner, lighter, ...
- KULR Technology Successfully Completes 200 Amp-Hour Battery Fractional Thermal Runaway Calorimetry Test for EV Customeron May 7, 2024 at 5:59 am
This technology was eventually licensed by KULR Technology Corporation on an exclusive basis in 2023. With this technique, KULR can characterize total energy yield, fractional energy yield, and mass ...
The Latest Google Headlines on:
Stem cell technology
[google_news title=”” keyword=”Stem cell technology” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on:
Regenerative therapies for spinal cord injuries and diseases
- Red light therapy for repairing spinal cord injury passes milestoneon May 6, 2024 at 6:43 am
Patients with spinal cord injury (SCI) could benefit from a future treatment to repair nerve connections using red and near-infrared light.
- Bone and Spine Newson May 5, 2024 at 5:00 pm
Spinal Cord ... injuries, including repetitive overuse changes and fractures, based on the maturity of their bones, according to a new ... Repairing Nerve Cells After Injury and in Chronic Disease ...
- Lineage Receives Grant From California Institute for Regenerative Medicine (CIRM)on April 30, 2024 at 5:00 am
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced that the Company ...
- Lineage Receives Grant From California Institute for Regenerative Medicine (CIRM)on April 30, 2024 at 1:00 am
The 2 nd SCIIS builds upon a successful inaugural event held in 2023 and will connect a diverse set of stakeholders in the field of spinal cord injury (SCI). This year’s event aims to accelerate ...
- Spinal Cord Injury Damages Metabolism, and Scientists Now Know Whyon April 29, 2024 at 3:40 am
The team also has identified a potential treatment to ward off illnesses ... function,” Tedeschi said. Heart disease and type 2 diabetes are among the leading causes of death in people with a spinal ...
- Nanotechnology for Treatment of Stroke and Spinal Cord Injuryon April 26, 2024 at 5:00 pm
Spinal cord injury ... the intrinsic regenerative capacity of the spinal cord. Adult mesenchymal stem cells have promising therapeutic potential in human medicine for CNS cell therapy and are ...
- Spinal Cord Injury Alters Neuronal Activity and Triggers Fat Tissue Leakage in Miceon April 24, 2024 at 5:00 pm
Tedeschi said the combined findings suggest starting gabapentin treatment early after a spinal cord injury may protect against detrimental conditions involving fat tissue that lead to cardiometabolic ...
- NurExone Presenting on Revolutionary Spinal Cord Injury Therapy at European Conference on Exosomes and Regenerative Medicineon April 19, 2024 at 9:05 am
was invited to present on "Revolutionizing Spinal Cord Injury Treatment: Harnessing the Potential of Exosomes for Advanced Therapy in Comprehensive Approach" at the Exosomes of Europe conference ...
The Latest Google Headlines on:
Regenerative therapies for spinal cord injuries and diseases
[google_news title=”” keyword=”regenerative therapies for spinal cord injuries and diseases” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]